NSE filing, NSE: LUPIN. Summary written from the filing by ALFA Finder's alert engine.
Lupin Ltd: key numbers
- Share price
- ₹1,972.70
- Market cap
- ₹90,210 Cr
- Revenue (annual)
- ₹27,958 Cr
- Net profit (annual)
- ₹5,333 Cr
- P/E (TTM)
- 16.3×Sector 46.5×
- Promoter holding
- 46.84%-0.01% QoQ
- FII holding
- 23.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lupin Ltd
All →Lupin Business Update
Lupin Limited disclosed that the U.S. FDA concluded an inspection at its Goa manufacturing facility, closing with a Form-483 containing one observation. The company will respond within the stipulated timeframe.
Lupin Management Change
Lupin Limited appointed Mr. Brian Savage as President and Chief Legal Officer, effective October 22, 2026. He will oversee global legal, compliance, and IP functions.
Lupin Employee Stock Options
Lupin Limited has granted 40,157 stock options to employees under its existing ESOP scheme at an exercise price of ₹2.00 per share.
Lupin Board Meeting Date
Lupin Limited scheduled a Board meeting on November 03, 2026, to consider and approve its unaudited standalone and consolidated financial results.
Lupin Other Announcement
Lupin Limited received an ESG rating of 70 for FY26 from NSE Sustainability Ratings and Analytics. The assessment was independently prepared using publicly available information.
Lupin Regulatory Approval
Lupin Limited received U.S. FDA approval for its Abbreviated New Drug Application (ANDA) for Phytonadione Injectable Emulsion, USP (1 mg/0.5 mL single-dose prefilled syringe).
Other merger & restructuring announcements
All →Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr
Vraj Iron & Steel Merger & Restructuring Worth ₹4.55 Cr
Vraj Iron and Steel transferred 396,000 MVK Industries shares to promoter Gopal Sponge for Rs 4.55 Crore. The sale was completed on October 28, 2026.
- Value
- ₹4.55 Cr
KPIT Technologies Merger & Restructuring Worth ₹19.2 Cr
KPIT Technologies will incorporate a new Vietnam subsidiary for mobility engineering, with 100% control. The company commits USD 2 million (about Rs 19.20 Crore) in cash.
- Value
- ₹19.20 Cr
Megatherm Induction Merger & Restructuring
Megatherm Induction incorporated Sictech India Private Limited, a joint venture with Smart Induction Converter Technologies, holding 49%. The JV will manufacture and commercialise advanced Induction Converter Modules.
Eco Recycling Merger & Restructuring Worth ₹0.05 Cr
Eco Recycling incorporated a 50:50 joint venture, ERI India Private Limited, with Electronic Recyclers International. The company subscribed 50,000 shares for ₹0.05 Crore.
- Value
- ₹0.05 Cr